C-型凝集素样受体 (CTLRs) 是一类含有类似 C 型凝集素结构域,但不一定依赖钙离子识别配体的蛋白质受体。根据其细胞内信号传导基序可分为激活受体和抑制受体。CTLRs 能够识别病原体相关分子模式 (PAMPs) 和损伤相关分子模式 (DAMPs),在先天性免疫和适应性免疫中发挥重要作用。结合配体后,CTLRs 作为抗原摄取受体,将抗原内化呈递给 T 细胞,并激活 NF-κB、IFN 和炎性小体等多种信号通路,调节免疫细胞功能。CTLRs 表达或功能的异常与肿瘤、感染性疾病和自身免疫性疾病等密切相关[1][2]。
C-type Lectin-like Receptors (CTLRs) are a class of protein receptors that contain a C-type lectin-like domain but do not necessarily rely on calcium ions to recognize ligands. They are usually classified as activating or inhibitory receptors, based on their intracellular signaling motifs. CTLRs are capable of recognizing pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs), and play important roles in innate and adaptive immunity. After binding to ligands, CLRs act as antigen-uptake receptors, internalize antigens and present them to T cells, and activate multiple signaling pathways such as NF-κB, IFN, and inflammasomes to regulate the functions of immune cells. Abnormal expression or function of CLRs is closely related to cancer, infectious diseases, autoimmune diseases, and others[1][2].
Arabinoxylan Medium viscosity 是一种口服有效的 Dectin-1 (CLEC7A) 剪接变体调节剂、葡萄糖吸收抑制剂和食糜黏度增强剂,可抑制颗粒状 β-葡聚糖诱导的 Dectin-1A 激活并轻度抑制 Dectin-1B 激活,在经颗粒状 β-葡聚糖刺激的人树突状细胞中降低 IL-10 和 TNF-α 产生、提高 IL-4 和 IL-23 产生,同时支持抗真菌免疫应答,且不会激活 TLR2、TLR4 或 TLR5,单独刺激人树突状细胞时也不诱导细胞因子产生;此外,它能提高小肠食糜黏度,在大肠中被降解产生短链脂肪酸,降低葡萄糖吸收和胰岛素应答并改善葡萄糖稳态,在胃肠道中支持微生物发酵、有益菌群生长、阻止胆汁酸重吸收并延缓淀粉消化,可用于 2 型糖尿病、糖耐量受损和代谢综合征的相关研究。
Ulviprubart (ABC-008) 是一种靶向 KLRG1 受体的单克隆抗体,可选择性地消耗高度分化的细胞毒性 T 细胞,可用于包涵体肌炎 (IBM) 的研究。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号